Q1 2025 · 13F-HR
Vivo Capital, LLCholdings as filed
Filed 2025-05-12 · accession 0001213900-25-041737
$755.1M
Reported value
40
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 834203309 | SLNO | Soleno Therapeutics Inc | $318.5M | 42.2% | 4,458,294 | Common | SOLE |
| 925050106 | VRNA | Verona Pharma PLC | $91.3M | 12.1% | 1,438,785 | Common | SOLE |
| 374163103 | GERN | Geron Corp | $43.3M | 5.73% | 27,225,292 | Common | SOLE |
| 89532M101 | TRVI | Trevi Therapeutics Inc | $21.9M | 2.91% | 3,487,903 | Common | SOLE |
| G29687103 | AVDL | Avadel Pharmaceuticals PLC | $21.0M | 2.78% | 2,684,109 | Common | SOLE |
| 880881107 | 430 | Terns Pharmaceuticals Inc | $19.0M | 2.52% | 6,895,746 | Common | SOLE |
| 171757206 | CDTX | Cidara Therapeutics, Inc. | $14.7M | 1.95% | 684,276 | Common | SOLE |
| 00461U105 | ACRS | Aclaris Therapeutics, Inc. | $13.6M | 1.80% | 8,888,888 | Common | SOLE |
| 92790C104 | VRDN | Viridian Therapeutics Inc | $13.2M | 1.75% | 982,576 | Common | SOLE |
| 26818M108 | DYN | Dyne Therapeutics Inc | $11.7M | 1.54% | 1,114,960 | Common | SOLE |
| 68622P109 | ORIC | Oric Pharmaceuticals Inc | $11.6M | 1.54% | 2,080,450 | Common | SOLE |
| 45783C200 | TIL | Instil Bio Inc | $10.2M | 1.35% | 585,485 | Common | SOLE |
| 20451W101 | CMPS | Compass Pathway PLC | $9.6M | 1.27% | 3,362,385 | Common | SOLE |
| 24661P807 | DCTH | Delcath Systems, Inc. | $9.5M | 1.26% | 750,195 | Common | SOLE |
| 98937L105 | ZBIO | Zenas Biopharma Inc | $9.3M | 1.24% | 1,183,260 | Common | SOLE |
| 92337C203 | VSTM | Verastem Inc | $9.3M | 1.23% | 1,538,461 | Common | SOLE |
| 29479A108 | ERAS | Erasca Inc | $9.3M | 1.23% | 6,756,756 | Common | SOLE |
| 10919W405 | DRUG | Bright Minds Biosciences Inc | $9.1M | 1.20% | 251,572 | Common | SOLE |
| 89157D105 | TRML | Tourmaline Bio Inc. | $9.0M | 1.19% | 591,882 | Common | SOLE |
| 00289Y206 | ABEO | Abeona Therapeutics, Inc. | $8.8M | 1.16% | 1,842,751 | Common | SOLE |
| 04635X102 | CATBUSD | Astria Therapeutics Inc | $8.3M | 1.10% | 1,552,685 | Common | SOLE |
| 00973Y108 | AKRO | Akero Therapeutics Inc | $8.1M | 1.08% | 201,168 | Common | SOLE |
| 221015100 | CRVS | Corvus Pharmaceuticals Holdings | $7.1M | 0.94% | 2,234,566 | Common | SOLE |
| 20454B104 | CMPX | Compass Therapeutics Inc | $6.8M | 0.89% | 3,556,023 | Common | SOLE |
| 449778109 | IOBTQ | IO Biotech Inc | $6.7M | 0.89% | 6,173,439 | Common | SOLE |
| 19240Q201 | COGT | Cogent Biosciences Inc | $6.7M | 0.89% | 1,122,471 | Common | SOLE |
| 90466Y103 | — | Unicycive Therapeutics | $6.5M | 0.87% | 11,370,152 | Common | SOLE |
| 15102K100 | CELC | Celcuity Inc | $6.2M | 0.82% | 610,500 | Common | SOLE |
| 76200L309 | RZLT | Rezolute Inc | $6.1M | 0.81% | 2,112,432 | Common | SOLE |
| 81749D107 | SERA | Sera Prognostics Inc | $6.1M | 0.80% | 1,650,440 | Common | SOLE |
| 68062P106 | OLMA | Olema Pharmaceuticals Inc | $5.7M | 0.75% | 1,505,862 | Common | SOLE |
| 75915K309 | RGLS | Regulus Therapeutics Inc | $4.7M | 0.62% | 2,696,426 | Common | SOLE |
| 82686Q101 | SLN | Silence Therapeutics PLC | $3.1M | 0.41% | 1,105,454 | Common | SOLE |
| 86889P208 | SRZN | Surrozen Inc | $3.0M | 0.40% | 260,000 | Common | SOLE |
| 282559103 | ETNBGBP | 89Bio Inc | $2.7M | 0.36% | 376,804 | Common | SOLE |
| 097702104 | BOLT1EUR | Bolt Therapeutics Inc | $1.4M | 0.19% | 3,521,291 | Common | SOLE |
| 88032L605 | TENX | Tenax Therapeutics Inc | $1.4M | 0.18% | 208,333 | Common | SOLE |
| 01671P100 | ALLKGUSD | Allakos Inc | $174,228 | 0.02% | 765,500 | Common | SOLE |
| 01626L204 | ALGS | Aligos Therapeutics Inc | $84,142 | 0.01% | 10,199 | Common | SOLE |
| 74019P207 | DTIL | Precision Biosciences Inc | $22,301 | 0.00% | 4,675 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.